Insider buying on Sep 4, 2026
Insiders at 17 companies reported 25 open-market buys of their own stock on Sep 4, 2026. Plan trades are left out.
Newest first
WhoTradeCompanyValueTradedThe stock’s closing price from the first session on or after the trade day to the latest close, with the S&P 500 over the same days. A fact about the stock, not a result anyone earned.
Alfonso De AngoitiaDirectorBoughtRaised their holding by 192%
Liberty Latin AmericaLILA$6.56M313,104 shares at $20.95Sep 255d agoStock since trade−8.1%Sep 2, 2026 close $8.75 → Oct 23, 2026 close $8.04. S&P 500 −0.7% over the same days.
Alfonso De AngoitiaDirectorBoughtRaised their holding by 12%Liberty Latin AmericaLILA$363.3K17,596 shares at $20.65Sep 156d agoStock since trade−6.1%Sep 1, 2026 close $8.56 → Oct 23, 2026 close $8.04. S&P 500 −0.2% over the same days.
Alfonso De AngoitiaDirectorBoughtNew holdingLiberty Latin AmericaLILA$3.06M145,490 shares at $21.00Aug 3157d agoStock since trade−6.6%Aug 31, 2026 close $8.61 → Oct 23, 2026 close $8.04. S&P 500 −0.9% over the same days.
Peter AltmanPresident and CEOBoughtRaised their holding by 0.2%
BioCardiaBCDA$872.00800 shares at $1.09Sep 354d agoStock since trade−15.5%Sep 3, 2026 close $1.09 → Oct 23, 2026 close $0.92. S&P 500 −1.7% over the same days.
Oliver EngertChief Administrative OfficerBoughtRaised their holding by 9.2%
EnovisENOV$100K5,140 shares at $19.46Sep 354d agoStock since trade+8.7%Sep 3, 2026 close $19.40 → Oct 23, 2026 close $21.08. S&P 500 −1.7% over the same days.
Oliver EngertChief Administrative OfficerBoughtRaised their holding by 4.6%EnovisENOV$49.9K2,458 shares at $20.32Sep 255d agoStock since trade+4.4%Sep 2, 2026 close $20.20 → Oct 23, 2026 close $21.08. S&P 500 −0.7% over the same days.
Damien McDonaldChief Executive OfficerBoughtRaised their holding by 5.6%EnovisENOV$249.6K13,035 shares at $19.15Sep 453d agoStock since trade+13.6%Sep 4, 2026 close $18.56 → Oct 23, 2026 close $21.08. S&P 500 −1.3% over the same days.
Brian N. CherryDirectorBoughtRaised their holding by 167%
Atara BiotherapeuticsATRA$1000K104,166 shares at $9.60Sep 453d agoStock since trade−4.2%Sep 4, 2026 close $9.76 → Oct 21, 2026 close $9.35. S&P 500 +0.4% over the same days.
Hartree PartnersMajor shareholderBoughtRaised their holding by 0.1%
Hudson TechnologiesHDSN$27.1K5,317 shares at $5.10Sep 255d agoStock since trade+4.9%Sep 2, 2026 close $5.12 → Oct 23, 2026 close $5.37. S&P 500 −0.7% over the same days.
Len SturmDirectorBoughtRaised their holding by 5.2%
Dream Finders HomesDFH$20.2K1,500 shares at $13.47Sep 354d agoStock since trade−25.7%Sep 3, 2026 close $13.80 → Oct 23, 2026 close $10.25. S&P 500 −1.7% over the same days.